RCM Technologies (RCMT) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
12 Nov, 2026Executive summary
Virtual annual meeting scheduled for Dec. 17, 2026, at 4:00 p.m. ET; record date Oct. 21, 2026, with 7,131,213 common shares outstanding and one vote per share.
Agenda: elect four directors, ratify WithumSmith + Brown as auditor for FY ending Jan. 2, 2027, and hold an advisory vote on 2025 named executive officer compensation.
Voting matters and shareholder proposals
Board recommends FOR Bradley S. Vizi, Chigozie O. Amadi, Swarna Srinivas Kakodkar and Jayanth S. Komarneni; nominees require a majority of votes cast for and against.
Board recommends FOR auditor ratification and the non-binding advisory vote approving 2025 named executive officer compensation; future pay decisions will consider say-on-pay results.
Proposals for inclusion in the 2027 proxy are due by July 15, 2027; advance-notice proposals and nominations are due Aug. 19–Sept. 18, 2027, assuming the meeting is Dec. 17, 2027.
Board of directors and corporate governance
Board comprises four director nominees, including three independent directors; all members of the Audit, Compensation, and Nominating & Corporate Governance committees are independent.
Swarna Srinivas Kakodkar serves as Lead Independent Director; Bradley S. Vizi is Executive Chairman and President.
Board held five meetings in FY ended Jan. 3, 2026; each director attended at least 75% of Board and assigned committee meetings, with independent-director executive sessions at each Board meeting.
Revised ownership guidelines set multiples at 6x base salary for the CEO and CFO, 2x for specified senior executives, and 5x for non-employee directors; succession planning identified potential successors for executive officers and major business-unit leaders.
Latest events from RCM Technologies
- Revenue and earnings advanced, while margins eased and control weaknesses persist.RCMT
Q3 2027 - Q2 2026 revenue up 20% to $93.8M, net income $4.9M, strong Engineering growth, internal control remediation ongoing.RCMT
Q2 2026 - Revenue fell 1.7% to $83M, with net income at $3.8M and adjusted EBITDA up to $8.1M.RCMT
Q1 2026 - Double-digit revenue and profit growth, with robust cash flow and margin stability.RCMT
Q4 2025 - Virtual meeting to elect directors, ratify auditor, and approve executive pay, with focus on governance.RCMT
Proxy Filing - Healthcare and engineering drove Q3 gains, but net income and cash flow declined year-over-year.RCMT
Q3 2024 - Q2 revenue and EBITDA rose, led by engineering and healthcare, with strong cash flow and buybacks.RCMT
Q2 2024 - Q1 2025 saw 17% revenue growth, higher earnings, and strong cash flow with share repurchases.RCMT
Q1 2025 - 2024 revenue rose 5.8% but profit fell; double-digit EBITDA growth targeted for 2025.RCMT
Q4 2024